VIR Vir Biotechnology, Inc.
Nasdaq · SEC CIK 1706431 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $21.00M 38 sales by 10 insiders
- Filings on record
- 298 since 2021-07-06, latest 2026-08-12 14:30
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| SVF Endurance (Cayman) Ltd | 10% | — | $9.38M |
| SB INVESTMENT ADVISERS (UK) LTD | 10% | — | $5.72M |
| SOFTBANK VISION FUND (AIV M1) L.P. | 10% | — | $2.76M |
| SATO VICKI L | Dir | — | $1.73M |
| De Backer Marianne | Pres, CEO, Dir | — | $946.9K |
| de Verneuil Vanina | EVP, GC, Corp Sec | — | $217.7K |
| Sabatini Brent | SVP, CAO | — | $113.1K |
| O'Byrne Jason | EVP, CFO | — | $68.9K |
| Eisner Mark | EVP, Chief Medical Off | — | $49.5K |
| Napolitano Janet | Dir | — | $30.2K |
Transactions 390
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-12 14:30 | 2026-08-11 | VIR | MORE ROBERT J | Dir | J - Other | $0.00 | -8,000 | 40.7K | -16% | $0 | |
| I | 2026-08-12 14:30 | 2026-08-11 | VIR | MORE ROBERT J | Dir | J - Other | $0.00 | +8,000 | 517.9K | +2% | $0 |
| DM | 2026-06-10 18:21 | 2026-06-09 | VIR | Coughlin Timothy | Dir | A - Grant | $0.00 | +16.0K | 16.0K | New | $0 |
| T | 2026-06-02 17:35 | 2026-06-01 | VIR | Napolitano Janet | Dir | S - Sale | $9.45 | -3,200 | 21.2K | -13% | -$30.2K |
| T | 2026-06-02 17:31 | 2026-06-01 | VIR | Sabatini Brent | SVP, CAO | S - Sale | $9.45 | -379 | 61.9K | -0.6% | -$3,582 |
| D | 2026-05-28 19:25 | 2026-05-27 | VIR | Sigal Charles Elliott | Dir | A - Grant | $0.00 | +8,000 | 39.8K | +25% | $0 |
| D | 2026-05-28 19:25 | 2026-05-27 | VIR | Napolitano Janet | Dir | A - Grant | $0.00 | +8,000 | 24.4K | +49% | $0 |
| D | 2026-05-28 19:25 | 2026-05-27 | VIR | MORE ROBERT J | Dir | A - Grant | $0.00 | +8,000 | 48.7K | +20% | $0 |
| D | 2026-05-28 19:24 | 2026-05-27 | VIR | Hatfield Jeffrey S. | Dir | A - Grant | $0.00 | +8,000 | 39.8K | +25% | $0 |
| D | 2026-05-28 19:24 | 2026-05-27 | VIR | Farid Ramy | Dir | A - Grant | $0.00 | +8,000 | 32.0K | +33% | $0 |
| D | 2026-05-28 19:23 | 2026-05-27 | VIR | BISCHOFBERGER NORBERT W | Dir | A - Grant | $0.00 | +8,000 | 21.3K | +60% | $0 |
| T | 2026-05-04 12:35 | 2026-05-01 | VIR | SATO VICKI L | Dir | S - Sale | $10.05 | -22.0K | 1.08M | -2% | -$221.0K |
| 2026-04-30 17:43 | 2026-04-29 | VIR | De Backer Marianne | Pres, CEO, Dir | J - Other | $0.00 | -233.5K | 714.6K | -25% | $0 | |
| I | 2026-04-30 17:43 | 2026-04-29 | VIR | De Backer Marianne | Pres, CEO, Dir | J - Other | $0.00 | +233.5K | 286.6K | +440% | $0 |
| T | 2026-04-07 16:50 | 2026-04-06 | VIR | De Backer Marianne | Pres, CEO, Dir | S - Sale | $9.16 | -72.6K | 948.1K | -7% | -$664.4K |
| T | 2026-04-02 10:46 | 2026-04-01 | VIR | SATO VICKI L | Dir | S - Sale | $9.07 | -22.0K | 1.10M | -2% | -$199.6K |
| 2026-03-24 | 2026-03-23 | VIR | Sabatini Brent | SVP, CAO | S - Sale | $9.12 | -7,711 | 61.9K | -11% | -$70.3K | |
| 2026-03-23 | 2026-03-20 | VIR | O'Byrne Jason | EVP, CFO | J - Other | $0.00 | -2,500 | 160.1K | -2% | $0 | |
| I | 2026-03-23 | 2026-03-20 | VIR | O'Byrne Jason | EVP, CFO | J - Other | $0.00 | +2,500 | 2,500 | New | $0 |
| M | 2026-03-03 | 2026-03-02 | VIR | SATO VICKI L | Dir | S - Sale | $9.50 | -22.0K | 1.12M | -2% | -$209.1K |
| D | 2026-02-26 | 2026-02-24 | VIR | SATO VICKI L | Dir | M - OptEx | $1.49 | +42.4K | 1.19M | +4% | +$63.1K |
| DM | 2026-02-26 | 2026-02-24 | VIR | SATO VICKI L | Dir | S - Sale+OE | $9.75 | -42.4K | 1.14M | -4% | -$413.3K |
| 2026-02-26 | 2026-02-24 | VIR | Sabatini Brent | SVP, CAO | S - Sale | $9.53 | -1,430 | 69.6K | -2% | -$13.6K | |
| 2026-02-26 | 2026-02-24 | VIR | De Backer Marianne | CEO, Dir | S - Sale | $9.53 | -14.8K | 1.02M | -1% | -$140.7K | |
| 2026-02-26 | 2026-02-24 | VIR | O'Byrne Jason | EVP, CFO | S - Sale | $9.53 | -1,634 | 162.6K | -1.0% | -$15.6K | |
| M | 2026-02-26 | 2026-02-24+ | VIR | de Verneuil Vanina | EVP, GC, Corp Sec | S - Sale | $9.77 | -16.8K | 126.7K | -12% | -$164.2K |
| M | 2026-02-26 | 2026-02-24+ | VIR | Eisner Mark | EVP, Chief Medical Off | S - Sale | $9.69 | -3,505 | 155.9K | -2% | -$34.0K |
| D | 2026-02-24 | 2026-02-22 | VIR | De Backer Marianne | CEO, Dir | A - Grant | $0.00 | +285.0K | 1.05M | +37% | $0 |
| D | 2026-02-24 | 2026-02-23 | VIR | De Backer Marianne | CEO, Dir | S - Sale | $7.45 | -19.0K | 1.04M | -2% | -$141.8K |
| D | 2026-02-24 | 2026-02-22 | VIR | de Verneuil Vanina | EVP, GC, Corp Sec | A - Grant | $0.00 | +55.0K | 134.2K | +69% | $0 |
| D | 2026-02-24 | 2026-02-23 | VIR | de Verneuil Vanina | EVP, GC, Corp Sec | S - Sale | $7.45 | -4,445 | 129.8K | -3% | -$33.1K |
| D | 2026-02-24 | 2026-02-22 | VIR | Sabatini Brent | SVP, CAO | A - Grant | $0.00 | +25.0K | 72.9K | +52% | $0 |
| D | 2026-02-24 | 2026-02-23 | VIR | Sabatini Brent | SVP, CAO | S - Sale | $7.45 | -1,829 | 71.0K | -3% | -$13.6K |
| D | 2026-02-24 | 2026-02-22 | VIR | O'Byrne Jason | EVP, CFO | A - Grant | $0.00 | +55.0K | 166.3K | +49% | $0 |
| D | 2026-02-24 | 2026-02-23 | VIR | O'Byrne Jason | EVP, CFO | S - Sale | $7.45 | -2,089 | 164.2K | -1% | -$15.6K |
| D | 2026-02-24 | 2026-02-22 | VIR | Eisner Mark | EVP, Chief Medical Off | A - Grant | $0.00 | +55.0K | 159.6K | +53% | $0 |
| D | 2026-02-24 | 2026-02-23 | VIR | Eisner Mark | EVP, Chief Medical Off | S - Sale | $7.45 | -2,089 | 157.5K | -1% | -$15.6K |
| 2026-02-18 | 2026-02-13 | VIR | Sabatini Brent | SVP, CAO | S - Sale | $7.79 | -1,530 | 47.9K | -3% | -$11.9K | |
| 2026-02-03 | 2026-02-02 | VIR | SATO VICKI L | Dir | S - Sale | $7.71 | -22.0K | 1.14M | -2% | -$169.6K | |
| 2026-01-05 | 2026-01-02 | VIR | SATO VICKI L | Dir | S - Sale | $5.93 | -22.0K | 1.17M | -2% | -$130.5K | |
| I | 2025-12-03 | 2025-12-01 | VIR | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $5.98 | -191.9K | 13.73M | -1% | -$1.15M |
| 2025-12-02 | 2025-12-01 | VIR | SATO VICKI L | Dir | S - Sale | $6.00 | -22.0K | 1.19M | -2% | -$132.0K | |
| MI | 2025-12-01 | 2025-11-26+ | VIR | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | S - Sale | $6.41 | -189.4K | 13.92M | -1% | -$1.21M |
| MI | 2025-11-26 | 2025-11-24+ | VIR | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $6.27 | -463.8K | 14.11M | -3% | -$2.91M |
| 2025-11-18 | 2025-11-17 | VIR | O'Byrne Jason | EVP, CFO | S - Sale | $5.56 | -6,799 | 110.7K | -6% | -$37.8K | |
| 2025-11-07 | 2025-11-05 | VIR | de Verneuil Vanina | EVP, GC, Corp Sec | S - Sale | $5.16 | -2,385 | 78.2K | -3% | -$12.3K | |
| 2025-11-04 | 2025-11-03 | VIR | de Verneuil Vanina | EVP, GC | S - Sale | $5.86 | -1,365 | 80.6K | -2% | -$7,999 | |
| 2025-11-04 | 2025-11-03 | VIR | SATO VICKI L | Dir | S - Sale | $5.64 | -22.0K | 1.21M | -2% | -$124.1K | |
| MI | 2025-10-30 | 2025-10-28+ | VIR | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $6.50 | -24.6K | 14.57M | -0.2% | -$159.6K |
| MI | 2025-10-28 | 2025-10-24+ | VIR | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $6.01 | -113.1K | 14.66M | -0.8% | -$680.0K |
| MI | 2025-10-24 | 2025-10-22+ | VIR | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $6.07 | -298.6K | 14.87M | -2% | -$1.81M |
| MI | 2025-10-22 | 2025-10-20+ | VIR | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $6.23 | -330.2K | 15.01M | -2% | -$2.06M |
| MI | 2025-10-17 | 2025-10-15+ | VIR | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $6.08 | -29.5K | 15.34M | -0.2% | -$179.5K |
| MI | 2025-10-14 | 2025-10-09+ | VIR | SOFTBANK VISION FUND (AIV M1) L.P. | 10% | S - Sale | $6.14 | -251.4K | 15.37M | -2% | -$1.54M |
| MI | 2025-10-09 | 2025-10-07+ | VIR | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $5.99 | -538.4K | 16.09M | -3% | -$3.22M |
| MI | 2025-10-07 | 2025-10-03+ | VIR | SVF Endurance (Cayman) Ltd | 10% | S - Sale | $5.58 | -524.3K | 16.23M | -3% | -$2.92M |
| 2025-10-02 | 2025-10-01 | VIR | SATO VICKI L | Dir | S - Sale | $5.84 | -22.0K | 1.23M | -2% | -$128.5K | |
| 2025-09-03 | 2025-09-02 | VIR | SATO VICKI L | Dir | S - Sale | $4.99 | -22.0K | 1.25M | -2% | -$109.8K | |
| 2025-08-04 | 2025-08-01 | VIR | SATO VICKI L | Dir | S - Sale | $4.99 | -22.0K | 1.28M | -2% | -$109.8K | |
| M | 2025-07-17 | 2025-07-15+ | VIR | Eisner Mark | EVP, Chief Medical Off | S - Sale | $5.47 | -10.4K | 108.2K | -9% | -$56.8K |
| 2025-07-02 | 2025-07-01 | VIR | SATO VICKI L | Dir | S - Sale | $5.10 | -22.0K | 1.30M | -2% | -$112.2K | |
| I | 2025-06-09 | 2025-06-09 | VIR | MORE ROBERT J | Dir | J - Other | $0.00 | +14.0K | 509.9K | +3% | $0 |
| 2025-06-09 | 2025-06-09 | VIR | MORE ROBERT J | Dir | J - Other | $0.00 | -14.0K | 40.7K | -26% | $0 | |
| I | 2025-06-06 | 2025-06-06 | VIR | BISCHOFBERGER NORBERT W | Dir | J - Other | $0.00 | +10.7K | 10.7K | New | $0 |
| 2025-06-06 | 2025-06-06 | VIR | BISCHOFBERGER NORBERT W | Dir | J - Other | $0.00 | -10.7K | 13.3K | -44% | $0 | |
| D | 2025-06-02 | 2025-05-30 | VIR | MORE ROBERT J | Dir | A - Grant | $0.00 | +8,000 | 54.7K | +17% | $0 |
| D | 2025-06-02 | 2025-06-02 | VIR | Napolitano Janet | Dir | S - Sale | $5.05 | -3,200 | 16.4K | -16% | -$16.2K |
| D | 2025-06-02 | 2025-05-30 | VIR | Napolitano Janet | Dir | A - Grant | $0.00 | +8,000 | 19.6K | +69% | $0 |
| D | 2025-06-02 | 2025-05-30 | VIR | Ramasastry Saira | Dir | A - Grant | $0.00 | +8,000 | 22.6K | +55% | $0 |
| D | 2025-06-02 | 2025-05-30 | VIR | SATO VICKI L | Dir | A - Grant | $0.00 | +8,000 | 1.32M | +0.6% | $0 |
| D | 2025-06-02 | 2025-05-30 | VIR | BISCHOFBERGER NORBERT W | Dir | A - Grant | $0.00 | +8,000 | 24.0K | +50% | $0 |
| D | 2025-06-02 | 2025-05-30 | VIR | Sigal Charles Elliott | Dir | A - Grant | $0.00 | +8,000 | 31.8K | +34% | $0 |
| D | 2025-06-02 | 2025-05-30 | VIR | Hatfield Jeffrey S. | Dir | A - Grant | $0.00 | +8,000 | 31.8K | +34% | $0 |
| D | 2025-06-02 | 2025-05-30 | VIR | Farid Ramy | Dir | A - Grant | $0.00 | +8,000 | 24.0K | +50% | $0 |
| 2025-04-04 | 2025-04-03 | VIR | De Backer Marianne | CEO, Dir | S - Sale | $5.95 | -79.7K | 769.5K | -9% | -$474.3K | |
| 2025-02-27 | 2025-02-26 | VIR | de Verneuil Vanina | EVP, GC | S - Sale | $9.14 | -7,373 | 79.5K | -8% | -$67.4K | |
| D | 2025-02-25 | 2025-02-22 | VIR | Eisner Mark | EVP, Chief Medical Off | A - Grant | $0.00 | +40.0K | 115.0K | +53% | $0 |
| D | 2025-02-25 | 2025-02-22 | VIR | O'Byrne Jason | EVP, CFO | A - Grant | $0.00 | +40.0K | 115.0K | +53% | $0 |
| D | 2025-02-25 | 2025-02-22 | VIR | de Verneuil Vanina | EVP, GC | A - Grant | $0.00 | +35.0K | 92.0K | +61% | $0 |
| D | 2025-02-25 | 2025-02-24 | VIR | de Verneuil Vanina | EVP, GC | S - Sale | $9.45 | -5,140 | 86.8K | -6% | -$48.6K |
| 2025-02-25 | 2025-02-24 | VIR | HANLY ANN M. | EVP, CTO | S - Sale | $9.45 | -14.2K | 117.9K | -11% | -$133.9K | |
| D | 2025-02-25 | 2025-02-24 | VIR | De Backer Marianne | CEO, Dir | S - Sale | $9.45 | -16.1K | 849.2K | -2% | -$152.4K |
| D | 2025-02-25 | 2025-02-22 | VIR | De Backer Marianne | CEO, Dir | A - Grant | $0.00 | +240.0K | 865.3K | +38% | $0 |
| D | 2025-02-25 | 2025-02-24 | VIR | Sabatini Brent | SVP, CAO | S - Sale | $9.45 | -1,562 | 46.6K | -3% | -$14.8K |
| D | 2025-02-25 | 2025-02-22 | VIR | Sabatini Brent | SVP, CAO | A - Grant | $0.00 | +20.0K | 48.2K | +71% | $0 |
| 2025-02-25 | 2025-02-24 | VIR | SCANGOS GEORGE A | Dir | S - Sale | $9.45 | -10.1K | 698.2K | -1% | -$95.0K | |
| 2025-02-19 | 2025-02-18 | VIR | SCANGOS GEORGE A | Dir | S - Sale | $9.81 | -11.0K | 708.3K | -2% | -$107.6K | |
| 2025-02-14 | 2025-02-13 | VIR | Sabatini Brent | SVP, CAO | S - Sale | $9.15 | -1,562 | 28.2K | -5% | -$14.3K | |
| 2025-01-08 | 2025-01-08 | VIR | SATO VICKI L | Dir | S - Sale | $12.52 | -11.0K | 1.31M | -0.8% | -$137.2K | |
| 2024-12-04 | 2024-12-02 | VIR | de Verneuil Vanina | EVP, GC | S - Sale | $8.22 | -76 | 57.0K | -0.1% | -$624.72 | |
| D | 2024-11-18 | 2024-11-15 | VIR | O'Byrne Jason | EVP, CFO | A - Grant | $0.00 | +75.0K | 75.0K | New | $0 |
| 2024-11-07 | 2024-11-06 | VIR | de Verneuil Vanina | EVP, GC | S - Sale | $10.11 | -4,397 | 57.0K | -7% | -$44.5K | |
| M | 2024-11-05 | 2024-11-01+ | VIR | de Verneuil Vanina | EVP, GC | S - Sale | $8.62 | -3,750 | 63.7K | -6% | -$32.3K |
| MI | 2024-10-24 | 2024-10-23 | VIR | SCANGOS GEORGE A | Dir | J - Other | $0.00 | -598.3K | 598.3K | -50% | $0 |
| 2024-10-24 | 2024-10-23 | VIR | SCANGOS GEORGE A | Dir | J - Other | $0.00 | +598.3K | 719.3K | +494% | $0 | |
| 2024-09-10 | 2024-09-09 | VIR | Napolitano Janet | Dir | S - Sale | $7.80 | -12.2K | 11.6K | -51% | -$95.1K | |
| D | 2024-07-16 | 2024-07-15 | VIR | Eisner Mark | EVP, Chief Medical Off | A - Grant | $0.00 | +75.0K | 75.0K | New | $0 |
| 2024-06-12 | 2024-06-12 | VIR | De Backer Marianne | CEO, Dir | J - Other | $0.00 | -53.1K | 625.3K | -8% | $0 | |
| I | 2024-06-12 | 2024-06-12 | VIR | De Backer Marianne | CEO, Dir | J - Other | $0.00 | +53.1K | 53.1K | New | $0 |
| 2024-06-12 | 2024-06-11 | VIR | Ramasastry Saira | Dir | S - Sale | $10.95 | -4,000 | 14.6K | -21% | -$43.8K |
Purchase Sale Sale after option exercise All abbreviations